Partner Content Partner Content How digital connectivity is driving faster patient access Sotiria Papanicolaou's take on digital innovation
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
